0001104659-19-059505.txt : 20191104
0001104659-19-059505.hdr.sgml : 20191104
20191104161550
ACCESSION NUMBER: 0001104659-19-059505
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191031
FILED AS OF DATE: 20191104
DATE AS OF CHANGE: 20191104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Love Colin
CENTRAL INDEX KEY: 0001376493
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38596
FILM NUMBER: 191189987
MAIL ADDRESS:
STREET 1: C/O REPLIMUNE GROUP, INC.
STREET 2: 18 COMMERCE WAY
CITY: WOBURN
STATE: MA
ZIP: 10801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Replimune Group, Inc.
CENTRAL INDEX KEY: 0001737953
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 822082553
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 500 UNICORN PARK
CITY: WOBURN
STATE: DE
ZIP: 01801
BUSINESS PHONE: (781) 222-9600
MAIL ADDRESS:
STREET 1: 500 UNICORN PARK
CITY: WOBURN
STATE: DE
ZIP: 01801
4
1
a4.xml
4
X0306
4
2019-10-31
0
0001737953
Replimune Group, Inc.
REPL
0001376493
Love Colin
C/O REPLIMUNE GROUP, INC.
18 COMMERCE WAY
WOBURN
MA
01801
0
1
0
0
Chief Operating Officer
Common Stock
2019-10-31
4
S
0
11250
17.00
D
1096524
D
The sale reported on this Form 4 was made by the reporting person pursuant to a trading plan adopted on March 7, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.
Following the sale reported on this Form 4, the reporting person continues to beneficially own 1,096,524 shares of the Issuer's common stock. The reporting person also holds options to acquire 328,103 shares of the Issuer's common stock, 115,169 of which are exercisable as of the date hereof.
/s/ Robert Coffin, attorney-in-fact
2019-11-04